Sprout Pharmaceuticals, Inc. — Form D/A

Sprout Pharmaceuticals, Inc. of RALEIGH, NC, a company, filed a Form D amendment with the SEC on 2012-07-11. The offering totals $20.0M, of which $20.0M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (36)

Showing 25 of 36 people.

NameRoleLocation
Douglas S. EckertDirectorRaleigh, NC
Robert S. WhiteheadDirectorRaleigh, NC
Douglas S. EckertExecutive OfficerRaleigh, NC
Matthew S. PetzoldExecutive OfficerRaleigh, NC
Fred S. PrudenExecutive OfficerRaleigh, NC
Cynthia S. WhiteheadExecutive OfficerRaleigh, NC
Robert S. WhiteheadExecutive OfficerRaleigh, NC
W. Robert DahlDirectorRaleigh, NC
Cynthia WhiteheadDirectorSanta Rosa Beach, FL
Cynthia WhiteheadExecutive OfficerSanta Rosa Beach, FL
Douglas S EckertDirectorRaleigh, NC
Douglas S EckertExecutive OfficerRaleigh, NC
Josephine S TorrenteExecutive OfficerRaleigh, NC
Rich S FrancoExecutive OfficerRaleigh, NC
Braxton Robert GoodrichDirectorRaleigh, NC
Richard Robert DeSchutterDirectorRaleigh, NC
Trygve Robert MikkelsenDirectorRaleigh, NC
Michael Robert FordDirectorRaleigh, NC
Trygve W MikkelsenDirectorRaleigh, NC
Anne S TomalinExecutive OfficerRaleigh, NC
Richard W DeSchutterDirectorRaleigh, NC
Robert W DahlDirectorRaleigh, NC
Douglas W EckertDirectorRaleigh, NC
Douglas W EckertExecutive OfficerRaleigh, NC
James S PrudenExecutive OfficerRaleigh, NC

Other filings by this issuer (6)

FiledFormOfferingSold
2015-06-08D$50.0M$50.0M
2014-07-11D$15.0M$4.3M
2013-07-26D/A$10.0M$10.0M
2013-06-25D$10.0M$4.8M
2012-06-29D$20.0M$17.6M
2012-03-21D$5.0M$5.0M

More